CLINICAL_TRIALS
trial_result
· 2019-07-02
Clinical Trial Update: Low Dose Ketamine Intra Nasal Traumatology [Phase 2]
Summary
Phase 2 clinical trial update evaluating low-dose ketamine given intranasally for trauma; the study is completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: University of Monastir | Conditions: Trauma | Phase 2 | Status: COMPLETED